PT TAISHO PHARMACEUTICAL INDONESIA TBK

Company Introduction PT TAISHO PHARMACEUTICAL INDONESIA TBK

PT TAISHO PHARMACEUTICAL INDONESIA TBK is a prominent pharmaceutical company operating in Indonesia. It is a subsidiary of Taisho Pharmaceutical Co., Ltd., a leading Japanese pharmaceutical company with a significant global presence.

The company is primarily a MANUFACTURER (FACTORY). It is engaged in the research, development, production, and marketing of various pharmaceutical products, including both prescription drugs and over-the-counter (OTC) medicines, as well as other consumer health products. Its operations include manufacturing facilities responsible for producing a wide range of health-related goods distributed throughout the Indonesian market.

As indicated by its "TBK" designation, which stands for "Terbuka" (publicly listed), PT TAISHO PHARMACEUTICAL INDONESIA TBK is a public company listed on the Indonesia Stock Exchange. This status reflects its established position and commitment to transparency within the Indonesian pharmaceutical industry.

Here are some products manufactured or marketed by PT Taisho Pharmaceutical Indonesia Tbk:

* Lipovitan

* Counterpain

* Tempra

* Pamol

* Adem Sari (Joint Venture with other company)